A bill to amend the Controlled Substances Act to list isotonitazene as a schedule I controlled substance.

Bill: 116-s-4648
Sponsor: full_name: Sen. Cotton, Tom [R-AR]
Introduced: 2020-09-22
Policy area: Crime and Law Enforcement
Subjects: Drug trafficking and controlled substances
Latest action: action_date: 2020-09-22
text: Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S5790-5791)

Summaries:
action_date: 2020-09-22
action_desc: Introduced in Senate
text: <p>This bill adds certain synthetic opioids to schedule I of the Controlled Substances Act. (A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)</p>

tv_txt: II 116th CONGRESS 2d Session S. 4648 IN THE SENATE OF THE UNITED STATES September 22, 2020 Mr. Cotton introduced the following bill; which was read twice and referred to the Committee on the Judiciary A BILL To amend the Controlled Substances Act to list isotonitazene as a schedule I controlled substance.

1. Scheduling of isotonitazene Schedule I of section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812(c) ) is amended by adding at the end the following: (e) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine, or which contains its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within that specific chemical designation. .